Last reviewed · How we verify

Anesthesia induction,propofol, remifentanil ,cisatracurium

Second Affiliated Hospital of Xi'an Jiaotong University · FDA-approved active Small molecule

Anesthesia induction,propofol, remifentanil ,cisatracurium is a Anesthetic combination (GABA-A agonist, opioid, neuromuscular blocker) Small molecule drug developed by Second Affiliated Hospital of Xi'an Jiaotong University. It is currently FDA-approved for Induction and maintenance of general anesthesia for surgical procedures.

This is a combination anesthesia regimen that uses propofol for sedation, remifentanil for analgesia, and cisatracurium for neuromuscular blockade to induce and maintain general anesthesia.

This is a combination anesthesia regimen that uses propofol for sedation, remifentanil for analgesia, and cisatracurium for neuromuscular blockade to induce and maintain general anesthesia. Used for Induction and maintenance of general anesthesia for surgical procedures.

At a glance

Generic nameAnesthesia induction,propofol, remifentanil ,cisatracurium
SponsorSecond Affiliated Hospital of Xi'an Jiaotong University
Drug classAnesthetic combination (GABA-A agonist, opioid, neuromuscular blocker)
TargetGABA-A receptor (propofol), mu opioid receptor (remifentanil), nicotinic acetylcholine receptor at neuromuscular junction (cisatracurium)
ModalitySmall molecule
Therapeutic areaAnesthesiology
PhaseFDA-approved

Mechanism of action

Propofol is a GABA-A receptor agonist that produces rapid sedation and hypnosis. Remifentanil is an ultra-short-acting opioid mu-receptor agonist that provides rapid analgesia and blunts stress responses. Cisatracurium is a non-depolarizing neuromuscular blocking agent that competitively antagonizes acetylcholine at the neuromuscular junction, producing skeletal muscle paralysis necessary for intubation and mechanical ventilation.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Anesthesia induction,propofol, remifentanil ,cisatracurium

What is Anesthesia induction,propofol, remifentanil ,cisatracurium?

Anesthesia induction,propofol, remifentanil ,cisatracurium is a Anesthetic combination (GABA-A agonist, opioid, neuromuscular blocker) drug developed by Second Affiliated Hospital of Xi'an Jiaotong University, indicated for Induction and maintenance of general anesthesia for surgical procedures.

How does Anesthesia induction,propofol, remifentanil ,cisatracurium work?

This is a combination anesthesia regimen that uses propofol for sedation, remifentanil for analgesia, and cisatracurium for neuromuscular blockade to induce and maintain general anesthesia.

What is Anesthesia induction,propofol, remifentanil ,cisatracurium used for?

Anesthesia induction,propofol, remifentanil ,cisatracurium is indicated for Induction and maintenance of general anesthesia for surgical procedures.

Who makes Anesthesia induction,propofol, remifentanil ,cisatracurium?

Anesthesia induction,propofol, remifentanil ,cisatracurium is developed and marketed by Second Affiliated Hospital of Xi'an Jiaotong University (see full Second Affiliated Hospital of Xi'an Jiaotong University pipeline at /company/second-affiliated-hospital-of-xi-an-jiaotong-university).

What drug class is Anesthesia induction,propofol, remifentanil ,cisatracurium in?

Anesthesia induction,propofol, remifentanil ,cisatracurium belongs to the Anesthetic combination (GABA-A agonist, opioid, neuromuscular blocker) class. See all Anesthetic combination (GABA-A agonist, opioid, neuromuscular blocker) drugs at /class/anesthetic-combination-gaba-a-agonist-opioid-neuromuscular-blocker.

What development phase is Anesthesia induction,propofol, remifentanil ,cisatracurium in?

Anesthesia induction,propofol, remifentanil ,cisatracurium is FDA-approved (marketed).

What are the side effects of Anesthesia induction,propofol, remifentanil ,cisatracurium?

Common side effects of Anesthesia induction,propofol, remifentanil ,cisatracurium include Hypotension, Bradycardia, Respiratory depression, Injection site pain (propofol), Muscle rigidity (remifentanil), Histamine release (cisatracurium).

What does Anesthesia induction,propofol, remifentanil ,cisatracurium target?

Anesthesia induction,propofol, remifentanil ,cisatracurium targets GABA-A receptor (propofol), mu opioid receptor (remifentanil), nicotinic acetylcholine receptor at neuromuscular junction (cisatracurium) and is a Anesthetic combination (GABA-A agonist, opioid, neuromuscular blocker).

Related